
Dr. Judge is a physician-scientist with extensive experience with mouse and human models of genetic disease. His current research utilizes induced pluripotent stem cells (iPSC) and gene editing to model disease and develop therapies. His primary interests focus on therapeutic gene editing for dominant neurologic disorders. He is funded by the NIH and Charcot-Marie-Tooth Association to evaluate therapeutic gene editing strategies in human and murine models of genetic neuropathy and published the first study of a gene editing approach for axonal neuropathy (Feliciano et al, 2021). Dr. Judge is an Affiliate Investigator in the Gladstone Institute of Data Science and Biotechnology as well as a practicing neonatologist at UCSF Benioff Children’s Hospital. He is an active mentor in both the clinical and laboratory realms and directs the fellowship program in Neonatal-Perinatal medicine.